{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:58:08Z","timestamp":1791475088578,"version":"4.3.4"},"reference-count":54,"publisher":"American Chemical Society (ACS)","issue":"19","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["MAPS 230109"],"award-info":[{"award-number":["MAPS 230109"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Magyar Tudom?nyos Akad?mia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat?si Fejleszt?si ?s Innov?ci?s Hivatal","doi-asserted-by":"publisher","award":["K147410"],"award-info":[{"award-number":["K147410"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat?si Fejleszt?si ?s Innov?ci?s Hivatal","doi-asserted-by":"publisher","award":["RRF-2.3.1-21-2022-00015"],"award-info":[{"award-number":["RRF-2.3.1-21-2022-00015"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"name":"H2020 Marie Sklodowska-Curie Actions","award":["956314"],"award-info":[{"award-number":["956314"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Covalent mechanism of action is a powerful way to modulate challenging drug targets. Here, we present a streamlined workflow that combines covalent fragment screening (electrophile first approach) and ligand-first strategy to identify covalent inhibitors targeting lysine residues in the allosteric latch site of SHP2 phosphatase. Supported by complementary computational and experimental analyses, this strategy enabled us to identify the first potent cell active allosteric covalent inhibitors acting at this site. Demonstrating the covalent tractability of the latch site opens further avenues for future optimization and therapeutic exploration of high-value allosteric SHP2 inhibitors.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01030","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:01:40Z","timestamp":1789761700000},"page":"21955-21971","source":"Crossref","is-referenced-by-count":0,"title":["Fragment-Based Covalent Targeting of Lysines at the Allosteric Latch Site of SHP2"],"prefix":"10.1021","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3140-3561","authenticated-orcid":true,"given":"Vincenzo","family":"Di Lorenzo","sequence":"first","affiliation":[{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"Budapest University of Technology and Economics , , Mu\u030begyetem rkp. 3 . , ,","place":["Budapest, Hungary, H-1111"]},{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noe\u0301mi","family":"Csorba","sequence":"additional","affiliation":[{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"Budapest University of Technology and Economics , , Mu\u030begyetem rkp. 3 . , ,","place":["Budapest, Hungary, H-1111"]},{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena\u0301ta","family":"Szabo\u0301","sequence":"additional","affiliation":[{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"Budapest University of Technology and Economics , , Mu\u030begyetem rkp. 3 . , ,","place":["Budapest, Hungary, H-1111"]},{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9679-3735","authenticated-orcid":true,"given":"Levente","family":"Kolla\u0301r","sequence":"additional","affiliation":[{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Roske","sequence":"additional","affiliation":[{"name":"Max-Delbru\u0308ck-Center for Molecular Medicine in the Helmholtz Association (MDC) , , Structural Biology , ,","place":["Berlin, Germany, 13125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Rand\u0335elovic\u0301","sequence":"additional","affiliation":[{"name":"National Institute of Oncology , , Ra\u0301th Gyo\u0308rgy u. 7-9 , ,","place":["Budapest, Hungary, 1122"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Bala\u0301zs","sequence":"additional","affiliation":[{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4088-3117","authenticated-orcid":true,"given":"Tibor Viktor","family":"Szalai","sequence":"additional","affiliation":[{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"Budapest University of Technology and Economics , , Mu\u030begyetem rkp. 3 . , ,","place":["Budapest, Hungary, H-1111"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6505-4120","authenticated-orcid":true,"given":"Nina-Louisa","family":"Efre\u0301m","sequence":"additional","affiliation":[{"name":"Leibniz-Forschungsinstitut fu\u0308r Molekulare Pharmakologie (FMP) , Medicinal Chemistry Campus Berlin-Buch, Robert-Ro\u0308ssle-Str. 10 , ,","place":["Berlin, Germany, 13125"]},{"name":"Karlsruhe Institute of Technology , , Fritz-Haber-Weg 6 , ,","place":["Karlsruhe, Germany, 76131"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levente","family":"Mihalovits","sequence":"additional","affiliation":[{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ti\u0301mea","family":"Imre","sequence":"additional","affiliation":[{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u0301zsef","family":"Simon","sequence":"additional","affiliation":[{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u0301zsef","family":"To\u0301va\u0301ri","sequence":"additional","affiliation":[{"name":"National Institute of Oncology , , Ra\u0301th Gyo\u0308rgy u. 7-9 , ,","place":["Budapest, Hungary, 1122"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1602-2330","authenticated-orcid":true,"given":"Marc","family":"Nazare\u0301","sequence":"additional","affiliation":[{"name":"Leibniz-Forschungsinstitut fu\u0308r Molekulare Pharmakologie (FMP) , Medicinal Chemistry Campus Berlin-Buch, Robert-Ro\u0308ssle-Str. 10 , ,","place":["Berlin, Germany, 13125"]},{"name":"Bielefeld University , , Universita\u0308tsstra\u00dfe 25 , ,","place":["Bielefeld, Germany, 33615"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Daumke","sequence":"additional","affiliation":[{"name":"Max-Delbru\u0308ck-Center for Molecular Medicine in the Helmholtz Association (MDC) , , Structural Biology , ,","place":["Berlin, Germany, 13125"]},{"name":"Leibniz-Forschungsinstitut fu\u0308r Molekulare Pharmakologie (FMP) , Medicinal Chemistry Campus Berlin-Buch, Robert-Ro\u0308ssle-Str. 10 , ,","place":["Berlin, Germany, 13125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9284-5160","authenticated-orcid":true,"given":"Pe\u0301ter","family":"A\u0301bra\u0301nyi-Balogh","sequence":"additional","affiliation":[{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"Budapest University of Technology and Economics , , Mu\u030begyetem rkp. 3 . , ,","place":["Budapest, Hungary, H-1111"]},{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1039-7809","authenticated-orcid":true,"given":"Gyo\u0308rgy M.","family":"Keseru\u030b","sequence":"additional","affiliation":[{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]},{"name":"Budapest University of Technology and Economics , , Mu\u030begyetem rkp. 3 . , ,","place":["Budapest, Hungary, H-1111"]},{"name":"HUN-REN Research Centre for Natural Sciences , , Magyar tudo\u0301sok ko\u0308ru\u0301tja 2 , ,","place":["Budapest, Hungary, 1117"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"5","key":"2026100811110111500_cit1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/S13402-022-00698-1","article-title":"A Comprehensive Review of SHP2 and Its Role in Cancer","volume":"45","author":"Asmamaw","year":"2022","journal-title":"Cell. Oncol."},{"key":"2026100811110111500_cit2","doi-asserted-by":"publisher","first-page":"1340726","DOI":"10.3389\/FIMMU.2024.1340726","article-title":"Tyrosine Phosphatase PTPN11\/SHP2 in Solid Tumors - Bull\u2019s Eye for Targeted Therapy?","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"key":"2026100811110111500_cit3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/BS.ACR.2023.03.003","article-title":"Setting Sail: Maneuvering SHP2 Activity and Its Effects in Cancer","volume":"160","author":"Welsh","year":"2023","journal-title":"Adv. Cancer Res."},{"issue":"7610","key":"2026100811110111500_cit4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nature18621","article-title":"Allosteric Inhibition of SHP2 Phosphatase Inhibits Cancers Driven by Receptor Tyrosine Kinases","volume":"535","author":"Chen","year":"2016","journal-title":"Nature"},{"issue":"12","key":"2026100811110111500_cit5","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1016\/J.APSB.2021.03.037","article-title":"Strategies to Overcome Drug Resistance Using SHP2 Inhibitors","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"2026100811110111500_cit6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.CBPA.2020.11.007","article-title":"Allosteric SHP2 Inhibitors in Cancer: Targeting the Intersection of RAS, Resistance, and the Immune Microenvironment","volume":"62","author":"Kerr","year":"2021","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"5","key":"2026100811110111500_cit7","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/MED.21890","article-title":"Crystallographic Landscape of SHP2 Provides Molecular Insights for SHP2 Targeted Drug Discovery","volume":"42","author":"Song","year":"2022","journal-title":"Med. Res. Rev."},{"key":"2026100811110111500_cit8","doi-asserted-by":"publisher","first-page":"116579","DOI":"10.1016\/J.EJMECH.2024.116579","article-title":"Advances in SHP2 Tunnel Allosteric Inhibitors and Bifunctional Molecules","volume":"275","author":"Guo","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"2026100811110111500_cit9","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1021\/ACS.JMEDCHEM.3C02118","article-title":"Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)","volume":"67","author":"Day","year":"2024","journal-title":"J. Med. Chem."},{"issue":"3","key":"2026100811110111500_cit10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1039\/D1MD00386K","article-title":"Recent Advances in the Discovery of Protein Tyrosine Phosphatase SHP2 Inhibitors","volume":"13","author":"Kong","year":"2022","journal-title":"RSC Med. Chem."},{"issue":"8","key":"2026100811110111500_cit11","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1021\/ACS.JMEDCHEM.1C02134","article-title":"The Ascension of Targeted Covalent Inhibitors","volume":"65","author":"Singh","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026100811110111500_cit12","doi-asserted-by":"publisher","first-page":"7668","DOI":"10.1021\/ACS.JMEDCHEM.3C01825","article-title":"Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: An Update","volume":"67","author":"Hillebrand","year":"2024","journal-title":"J. Med. Chem."},{"issue":"12","key":"2026100811110111500_cit13","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1039\/D2MD00216G","article-title":"Advanced Approaches of Developing Targeted Covalent Drugs","volume":"13","author":"Gai","year":"2022","journal-title":"RSC Med. Chem."},{"key":"2026100811110111500_cit14","doi-asserted-by":"publisher","first-page":"100217","DOI":"10.1016\/J.EJMCR.2024.100217","article-title":"Advancements, Challenges, and Future Frontiers in Covalent Inhibitors and Covalent Drugs: A Review","volume":"12","author":"Hameed","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"issue":"19","key":"2026100811110111500_cit15","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.4155\/FMC-2023-0243","article-title":"Targeted Covalent Inhibitors for Novel Therapeutics","volume":"15","author":"Zhang","year":"2023","journal-title":"Future Med. Chem."},{"issue":"3","key":"2026100811110111500_cit16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/J.CHEMBIOL.2023.11.010","article-title":"Profiling Nuclear Cysteine Ligandability and Effects on Nuclear Localization Using Proximity Labeling-Coupled Chemoproteomics","volume":"31","author":"Peng","year":"2024","journal-title":"Cell Chem. Biol."},{"issue":"6","key":"2026100811110111500_cit17","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1021\/ACSMEDCHEMLETT.4C00622","article-title":"Allosteric Covalent Inhibitors of the STAT3 Transcription Factor from Virtual Screening","volume":"16","author":"Szalai","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"issue":"18","key":"2026100811110111500_cit18","doi-asserted-by":"publisher","first-page":"2416963","DOI":"10.1002\/ADVS.202416963","article-title":"An Intracellular Peptide Library Screening Platform Identifies Irreversible Covalent Transcription Factor Inhibitors","volume":"12","author":"Brennan","year":"2025","journal-title":"Adv. Sci."},{"issue":"8","key":"2026100811110111500_cit19","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1021\/ACS.JMEDCHEM.3C02403","article-title":"Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer Therapy","volume":"67","author":"Kirschner","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026100811110111500_cit20","doi-asserted-by":"publisher","first-page":"115212","DOI":"10.1016\/J.EJMECH.2023.115212","article-title":"Covalent Fragment Mapping of KRasG12C Revealed Novel Chemotypes with in Vivo Potency","volume":"250","author":"Orgova\u0301n","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"19","key":"2026100811110111500_cit21","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.2410766122","article-title":"Blocking C-Terminal Processing of KRAS4b via a Direct Covalent Attack on the CaaX-Box Cysteine","volume":"122","author":"Maciag","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"18","key":"2026100811110111500_cit22","doi-asserted-by":"publisher","first-page":"15787","DOI":"10.1021\/JACS.5C03562","article-title":"Discovery of Carbodiimide Warheads to Selectively and Covalently Target Aspartic Acid in KRASG12D","volume":"147","author":"Sirocchi","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"39","key":"2026100811110111500_cit23","doi-asserted-by":"publisher","DOI":"10.1002\/ADVS.202506068","article-title":"Discovering Uncharted Binding Pockets on E3 Ligases Leads to the Identification of FBW7 Allosteric Modulators","volume":"12","author":"Marti\u0301nez-Cartro\u0301","year":"2025","journal-title":"Adv. Sci."},{"key":"2026100811110111500_cit24","doi-asserted-by":"publisher","first-page":"691093","DOI":"10.3389\/FCHEM.2021.691093","article-title":"Reversible Covalent PROTACs: Novel and Efficient Targeted Degradation Strategy","volume":"9","author":"Yuan","year":"2021","journal-title":"Front. Chem."},{"issue":"11","key":"2026100811110111500_cit25","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1021\/ACSCHEMBIO.8B01083","article-title":"Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications","volume":"14","author":"Ward","year":"2019","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"2026100811110111500_cit26","doi-asserted-by":"publisher","DOI":"10.1002\/CBIC.202400656","article-title":"Drug Discovery Approaches to Target E3 Ligases","volume":"26","author":"Rodri\u0301guez-Gimeno","year":"2025","journal-title":"ChemBioChem"},{"issue":"11","key":"2026100811110111500_cit27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/J.TIPS.2023.08.014","article-title":"Covalent Fragment Approaches Targeting Non-Cysteine Residues","volume":"44","author":"Csorba","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"2026100811110111500_cit28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/bs.armc.2020.10.001","article-title":"Design of Next-Generation Covalent Inhibitors: Targeting Residues beyond Cysteine","volume-title":"Annual Reports in Medicinal Chemistry","author":"Jones","year":"2020","edition":"1"},{"issue":"14","key":"2026100811110111500_cit29","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1021\/ACS.CHEMREV.5C00001","article-title":"Advancing Covalent Ligand and Drug Discovery beyond Cysteine","volume":"125","author":"Kim","year":"2025","journal-title":"Chem. Rev."},{"issue":"12","key":"2026100811110111500_cit30","doi-asserted-by":"publisher","first-page":"103799","DOI":"10.1016\/J.DRUDIS.2023.103799","article-title":"The Expanding Repertoire of Covalent Warheads for Drug Discovery","volume":"28","author":"Mehta","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"13","key":"2026100811110111500_cit31","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1021\/ACS.JMEDCHEM.4C01308","article-title":"Covalent Inhibitors: To Infinity and Beyond","volume":"67","author":"Raouf","year":"2024","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026100811110111500_cit32","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/s41557-021-00765-4","article-title":"A Proteome-Wide Atlas of Lysine-Reactive Chemistry","volume":"13","author":"Abbasov","year":"2021","journal-title":"Nat. Chem."},{"issue":"8","key":"2026100811110111500_cit33","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.70310","article-title":"Mapping the SHP2 Allosteric Pocket With Target-Biased Covalent Fragments","volume":"27","author":"Efre\u0301m","year":"2026","journal-title":"ChemBioChem"},{"key":"2026100811110111500_cit34","doi-asserted-by":"publisher","first-page":"112836","DOI":"10.1016\/j.ejmech.2020.112836","article-title":"An Electrophilic Warhead Library for Mapping the Reactivity and Accessibility of Tractable Cysteines in Protein Kinases","volume":"207","author":"Petri","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"2026100811110111500_cit35","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/cbic.202000700","article-title":"Assessment of Tractable Cysteines for Covalent Targeting by Screening Covalent Fragments","volume":"22","author":"Petri","year":"2020","journal-title":"ChemBioChem"},{"issue":"3","key":"2026100811110111500_cit36","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1021\/ACSCHEMBIO.7B00980","article-title":"Dual Allosteric Inhibition of SHP2 Phosphatase","volume":"13","author":"Fodor","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"2026100811110111500_cit37","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1080\/14756366.2022.2078968","article-title":"Design, Synthesis and Biological Evaluation of Novel Triazoloquinazolinone and Imidazoquinazolinone Derivatives as Allosteric Inhibitors of SHP2 Phosphatase","volume":"37","author":"Ye","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"2026100811110111500_cit38","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1080\/14756366.2021.1986491","article-title":"Design, Synthesis, and Biological Evaluation of Novel Triazoloquinazolinone Derivatives as SHP2 Protein Inhibitors","volume":"36","author":"Luo","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"2026100811110111500_cit39","doi-asserted-by":"publisher","first-page":"137320","DOI":"10.1016\/J.MOLSTRUC.2023.137320","article-title":"Crystal Structure, DFT Study, Hirshfeld Surface Analysis, Molecular Docking and Antitumor Activity of a Novel SHP2 Inhibitor","volume":"1301","author":"Song","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"4","key":"2026100811110111500_cit40","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/17460441.2022.2034783","article-title":"Electrophilic Warheads in Covalent Drug Discovery: An Overview","volume":"17","author":"Pe\u0301czka","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"issue":"12","key":"2026100811110111500_cit41","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/nchem.2826","article-title":"Global Profiling of Lysine Reactivity and Ligandability in the Human Proteome","volume":"9","author":"Hacker","year":"2017","journal-title":"Nat. Chem."},{"issue":"3","key":"2026100811110111500_cit42","doi-asserted-by":"publisher","DOI":"10.1002\/ANIE.202520594","article-title":"Covalent Activation of the C-Type Lectin DC-SIGN","volume":"65","author":"Lefe\u0300bre","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2026100811110111500_cit43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejmech.2018.10.010","article-title":"A Road Map for Prioritizing Warheads for Cysteine Targeting Covalent Inhibitors","volume":"160","author":"A\u0301bra\u0301nyi-Balogh","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"2026100811110111500_cit44","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1021\/acschembio.2c00633","article-title":"Profiling Sulfur(VI) Fluorides as Reactive Functionalities for Chemical Biology Tools and Expansion of the Ligandable Proteome","volume":"18","author":"Gilbert","year":"2023","journal-title":"ACS Chem. Biol."},{"issue":"5","key":"2026100811110111500_cit45","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1039\/c6md00017g","article-title":"Intrinsic Reactivity Profile of Electrophilic Moieties to Guide Covalent Drug Design:: N -\u03b1-Acetyl-l-Lysine as an Amine Nucleophile","volume":"7","author":"Dahal","year":"2016","journal-title":"Medchemcomm"},{"issue":"3","key":"2026100811110111500_cit46","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/PROT.22102","article-title":"Very Fast Prediction and Rationalization of PKa Values for Protein-Ligand Complexes","volume":"73","author":"Bas","year":"2008","journal-title":"Proteins:Struct. Funct. Bioinf."},{"issue":"2","key":"2026100811110111500_cit47","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/CT100578Z","article-title":"PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical p K a Predictions","volume":"7","author":"Olsson","year":"2011","journal-title":"J. Chem. Theory Comput."},{"issue":"7","key":"2026100811110111500_cit48","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1021\/CT200133Y","article-title":"Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values","volume":"7","author":"S\u00f8ndergaard","year":"2011","journal-title":"J. Chem. Theory Comput."},{"key":"2026100811110111500_cit49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/J.EJMECH.2016.03.056","article-title":"Synthesis of Triazoloquinazolinone Based Compounds as Tubulin Polymerization Inhibitors and Vascular Disrupting Agents","volume":"115","author":"Driowya","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"40","key":"2026100811110111500_cit50","doi-asserted-by":"publisher","DOI":"10.1002\/ANGE.202510763","article-title":"Cell-Active, Irreversible Covalent Inhibitors Targeting a Surface-Exposed Non-Catalytic Lysine on Aurora a Kinase by Using Squarate Chemistry","volume":"137","author":"Wang","year":"2025","journal-title":"Angew. Chem."},{"issue":"17","key":"2026100811110111500_cit51","doi-asserted-by":"publisher","first-page":"14693","DOI":"10.1021\/acs.jmedchem.4c01721","article-title":"Demystifying Functional Parameters for Irreversible Enzyme Inhibitors","volume":"67","author":"Heppner","year":"2024","journal-title":"J. Med. Chem."},{"issue":"5","key":"2026100811110111500_cit52","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1021\/acsmedchemlett.4c00054","article-title":"Fitting of Kinact and KI Values from Endpoint Pre-Incubation IC50 Data","volume":"15","author":"Mader","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"issue":"14","key":"2026100811110111500_cit53","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1021\/acs.biochem.0c00104","article-title":"Insight into the Therapeutic Selectivity of the Irreversible EGFR Tyrosine Kinase Inhibitor Osimertinib through Enzyme Kinetic Studies","volume":"59","author":"Zhai","year":"2020","journal-title":"Biochemistry"},{"key":"2026100811110111500_cit54","unstructured":"Case Study - COVALfinder to Study Irreversible EGFR Drugs| Enzymlogic. https:\/\/www.enzymlogic.com\/resources\/covalfinder-the-ideal-tool-for-irreversible-drug-discovery-programs\/(accessed 02 27, 2026)."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01030","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/19\/21955\/68560974\/jm6c01030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/19\/21955\/68560974\/jm6c01030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:30:10Z","timestamp":1791473410000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/19\/21955\/5433089\/Fragment-Based-Covalent-Targeting-of-Lysines-at"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":54,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,9,18]]},"published-print":{"date-parts":[[2026,10,8]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01030","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}